Back6-K2026-03-31· glm-5
BLTE · Belite Bio, Inc
0001104659-26-037376
SEC filingSummary
Belite Bio announced the availability of its annual report on Form 20-F for the year ended December 31, 2025, on the company website.
Key takeaways
- Annual report on Form 20-F filed with the SEC on March 31, 2026, containing audited financial statements.
- Shareholders can request a hard copy of the annual report free of charge.
- Filing satisfies Nasdaq Listing Rule 5250(d)(1)(C).